People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Biotech, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Watchmaker Genomics, Inc. | — | Biotech | Series B | $48.3M | $712.8M | 2020 |
| seqWell Inc. | — | Other Technology | Series A | $22.5M | $15.7M | 2022 |
| LTS1, Inc. | — | Other | Series A | $10.0M | $14.2M | 2021 |
Paul McEwan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul McEwan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher McGuinness | 2 | 3 |
| William Snider | 1 | 7 |
| Michael Finney | 1 | 6 |
| Victor Tong | 1 | 6 |
| Chad Souvignier | 1 | 4 |
| William McKenzie | 1 | 2 |
| Stephen Picone | 1 | 2 |
| Thomas Grant | 1 | 2 |
| Rob Wilson | 1 | 2 |
| Dan Calvo | 1 | 2 |
| David Mullarkey | 1 | 2 |
| Jack Leonard | 1 | 1 |
| Tom Grant | 1 | 1 |
| Christopher Boggess | 1 | 1 |
| Brian Kudlow | 1 | 1 |
| Brian Deneau | 1 | 1 |
| John Foskett | 1 | 1 |
| Joseph Mellor, Ph.D. | 1 | 1 |
| Joseph Mellor | 1 | 1 |
| Daniel Calvo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.